Search Prime Grants

HT94252510639

Project Grant

Overview

Grant Description
TARGETING A NOVEL IMMUNE CHECKPOINT RECEPTOR FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
Awardee
The Cleveland Clinic Foundation
Funding Goals
BREAKTHROUGH AWARD LEVELS 1 AND 2 - FUNDING LEVEL 2 - PARTNERING PI OPTION
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Cleveland, Ohio 441950001 United States
Geographic Scope
Single Zip Code
Related Opportunity
DoD Breast Cancer, Breakthrough Award (HT942524BCRPBTA12)
The Cleveland Clinic Foundation was awarded Project Grant HT94252510639 from Defense Health Agency in August 2025 with work to be completed primarily in Cleveland Ohio United States. The grant has a duration of 3 years and was awarded through assistance program 12.420 Military Medical Research and Development. The Project Grant was awarded through grant opportunity DoD Breast Cancer, Breakthrough Award.

Status
(Ongoing)

Last Modified 6/27/25

Period of Performance
8/1/25
Start Date
7/31/28
End Date
4.0% Complete

Funding Split
$0.0
Federal Obligation
$0.0
Non-Federal Obligation
$0.0
Total Obligated
100% Federal Funding
0% Non-Federal Funding

Additional Detail

Award ID FAIN
HT94252510639
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
TDGUJ1WA4UJ9
Awardee CAGE
1PZL9
Performance District
OH-11
Senators
Sherrod Brown
J.D. (James) Vance
Modified: 6/27/25